Chapter 12

Medications Used to Treat Parkinson’s Disease

Since Parkinson’s disease was first recognized more than two centuries ago, tremendous progress has been made in its treatment. Although there is currently no cure that completely stops or reverses the disease, modern medications can significantly reduce symptoms, improve movement, preserve independence, and enhance quality of life for many years. The primary goal of treatment is not simply to eliminate tremors or stiffness but to help individuals maintain their ability to work, exercise, communicate, enjoy family life, and participate fully in everyday activities.

The loss of dopamine-producing nerve cells is the central biological problem in Parkinson’s disease. As dopamine levels decline, communication between different parts of the brain becomes increasingly disrupted, leading to the characteristic symptoms of tremor, slowness of movement, rigidity, and impaired balance. Most medications used to treat Parkinson’s disease aim to restore dopamine activity or improve the brain’s ability to use the dopamine that remains.

Treatment is highly individualized. No single medication works equally well for every patient, and the choice of therapy depends on many factors, including age, symptom severity, occupation, lifestyle, overall health, cognitive function, and the presence of other medical conditions. Neurologists frequently adjust treatment over time because Parkinson’s disease is progressive, and medication needs change as symptoms evolve.

The Importance of Early Treatment

One common question asked after diagnosis is whether medication should begin immediately or be delayed. Modern medical practice generally recommends starting treatment when symptoms begin interfering with work, daily activities, exercise, or quality of life. There is little evidence that delaying medication provides long-term benefit, while untreated symptoms may reduce physical activity and independence.

Early treatment allows patients to remain active, maintain muscle strength, continue social participation, and engage more effectively in rehabilitation programs. Since regular exercise is one of the most valuable therapies for Parkinson’s disease, controlling symptoms early helps individuals remain physically active.

Levodopa: The Gold Standard

The most effective medication for Parkinson’s disease remains levodopa, often called L-DOPA. Introduced into clinical practice during the late 1960s, levodopa transformed the treatment of Parkinson’s disease and remains the cornerstone of therapy today.

Dopamine itself cannot cross the blood-brain barrier, a protective system that regulates which substances enter the brain. Levodopa, however, can cross this barrier. Once inside the brain, specialized enzymes convert levodopa into dopamine, replenishing depleted dopamine stores and improving communication between nerve cells.

Levodopa effectively treats the major motor symptoms of Parkinson’s disease, including bradykinesia, rigidity, resting tremor, and walking difficulties. Many patients experience dramatic improvement shortly after beginning treatment, often regaining abilities that had gradually become difficult.

Because levodopa is converted into dopamine outside the brain as well as inside it, it is almost always combined with another medication called carbidopa (or benserazide in some countries). Carbidopa blocks the conversion of levodopa outside the brain, allowing more medication to reach its target while reducing side effects such as nausea and vomiting.

This combination is marketed under various brand names depending on the country, but the principle remains the same: maximize dopamine production within the brain while minimizing unwanted effects elsewhere in the body.

Benefits of Levodopa

Levodopa often produces remarkable improvement in movement. Patients commonly notice:

• Reduced tremor
• Improved walking speed
• Less muscle stiffness
• Better balance during early disease
• Increased facial expression
• Clearer speech
• Improved handwriting
• Easier performance of daily activities
• Greater physical endurance

Many individuals describe levodopa as giving them “their life back” during the early years of treatment.

Possible Side Effects of Levodopa

Like all medications, levodopa can produce side effects. During the early stages of treatment, the most common include nausea, lightheadedness, dizziness, reduced blood pressure upon standing, and occasional sleepiness.

Taking medication with a small snack may reduce nausea, although high-protein meals can interfere with absorption in some individuals. Physicians often adjust dosage gradually to minimize side effects.

After several years of treatment, some patients develop motor fluctuations, in which medication benefits wear off before the next scheduled dose. Others develop dyskinesias, involuntary twisting or writhing movements associated with long-term therapy and disease progression.

These complications do not mean levodopa has stopped working. Instead, they reflect changes in the brain’s ability to store and regulate dopamine as Parkinson’s disease advances. Careful medication adjustments usually improve symptom control.

Dopamine Agonists

Another important group of medications consists of dopamine agonists. Unlike levodopa, these drugs are not converted into dopamine. Instead, they directly stimulate dopamine receptors within the brain, mimicking the action of natural dopamine.

Common dopamine agonists include:

• Pramipexole
• Ropinirole
• Rotigotine (available as a skin patch)
• Apomorphine (used primarily for sudden “off” episodes)

Dopamine agonists may be prescribed alone during the early stages of Parkinson’s disease, particularly in younger patients, or combined with levodopa during later stages to improve symptom control.

Because dopamine agonists have a longer duration of action than levodopa, they may reduce fluctuations between “on” and “off” periods.

Side Effects of Dopamine Agonists

Although effective, dopamine agonists may cause side effects such as:

• Sleepiness
• Sudden sleep attacks
• Swelling of the legs
• Nausea
• Dizziness
• Hallucinations
• Confusion in older adults

One particularly important complication is the development of impulse control disorders. Some individuals develop compulsive gambling, excessive shopping, overeating, or increased sexual behavior. These behaviors result from overstimulation of dopamine pathways involved in reward and motivation rather than personality changes.

Patients and family members should discuss these risks before treatment begins and promptly report any unusual behavioral changes.

MAO-B Inhibitors

Monoamine Oxidase-B (MAO-B) inhibitors help preserve dopamine by blocking the enzyme responsible for breaking it down within the brain.

Common MAO-B inhibitors include:

• Selegiline
• Rasagiline
• Safinamide

These medications provide modest improvement in symptoms during early disease and may enhance the effects of levodopa during later stages.

Because MAO-B inhibitors increase dopamine availability, they can reduce wearing-off symptoms and extend the duration of medication benefit.

Possible side effects include headache, insomnia, dizziness, nausea, and interactions with certain antidepressants or other medications. Patients should always inform healthcare providers about all medications they are taking to avoid harmful interactions.

COMT Inhibitors

Another group of medications, Catechol-O-Methyltransferase (COMT) inhibitors, prolongs the effect of levodopa by preventing its breakdown before it reaches the brain.

Common COMT inhibitors include:

• Entacapone
• Opicapone
• Tolcapone (used less frequently because of potential liver toxicity)

These medications are never used alone. Instead, they are prescribed alongside levodopa to increase its duration of action and reduce wearing-off periods.

Side effects may include diarrhea, orange-colored urine, nausea, increased dyskinesia, and low blood pressure. Tolcapone requires regular liver function monitoring because of its rare but serious risk of liver injury.

Amantadine

Originally developed as an antiviral medication, amantadine was later found to improve certain Parkinson’s disease symptoms.

Amantadine provides modest benefit for tremor, rigidity, and slowness of movement. More importantly, it has become an effective treatment for levodopa-induced dyskinesia, helping reduce involuntary movements without significantly worsening Parkinson’s symptoms.

Possible side effects include ankle swelling, dry mouth, dizziness, insomnia, hallucinations, and a distinctive purple, lace-like skin discoloration known as livedo reticularis.

Anticholinergic Medications

Before levodopa became widely available, anticholinergic medications were commonly used to treat Parkinson’s disease.

Examples include:

• Trihexyphenidyl
• Benztropine

These drugs may reduce tremor in selected younger patients but have limited benefit for bradykinesia or rigidity.

Because they commonly cause confusion, memory impairment, blurred vision, constipation, dry mouth, and urinary retention, they are generally avoided in older adults or individuals with cognitive impairment.

Adenosine A2A Receptor Antagonists

A newer class of medication includes adenosine A2A receptor antagonists, such as istradefylline.

Rather than directly affecting dopamine levels, these medications influence other brain pathways involved in movement control. They are typically added to levodopa therapy to reduce “off” time.

Although relatively new, they offer another option for patients experiencing medication fluctuations.

Continuous Dopaminergic Therapy

As Parkinson’s disease progresses, maintaining stable dopamine stimulation becomes increasingly important.

Several treatment strategies aim to provide continuous medication delivery, including:

• Extended-release levodopa formulations
• Long-acting dopamine agonists
• Rotigotine skin patches
• Continuous intestinal levodopa infusion
• Continuous apomorphine infusion

These approaches reduce fluctuations in dopamine levels, helping smooth motor performance throughout the day.

Medication Timing

One of the most important aspects of Parkinson’s disease treatment is taking medications exactly as prescribed.

Even small delays may allow symptoms to return, leading to increased stiffness, slower walking, freezing episodes, or tremor.

Many patients use alarms, smartphone reminders, pill organizers, or medication schedules to ensure timely dosing.

Hospital staff should also recognize the importance of maintaining precise medication timing during hospital admissions because missed doses may significantly worsen symptoms.

Food and Medication Interactions

Diet influences the effectiveness of levodopa.

Protein-rich foods such as meat, fish, eggs, and dairy products compete with levodopa for absorption in the small intestine and transport into the brain.

Some individuals notice that medication works better when taken 30 to 60 minutes before meals or one to two hours afterward. Others tolerate taking medication with light snacks if nausea occurs.

Dietary adjustments should always be discussed with healthcare providers to ensure adequate nutrition while optimizing medication effectiveness.

Managing Wearing-Off

After several years of treatment, many patients notice that medication effects gradually shorten.

Symptoms of wearing-off may include:

• Return of tremor
• Increased stiffness
• Slower walking
• Anxiety
• Pain
• Fatigue
• Difficulty speaking

Strategies for managing wearing-off include:

• Smaller but more frequent levodopa doses
• Extended-release formulations
• Adding MAO-B inhibitors
• Adding COMT inhibitors
• Adding dopamine agonists
• Considering advanced therapies such as Deep Brain Stimulation

Careful symptom diaries often help physicians identify wearing-off patterns and adjust treatment accordingly.

Medication Safety

Patients should never stop Parkinson’s medications suddenly unless instructed by a physician.

Abrupt withdrawal may lead to severe stiffness, high fever, confusion, muscle breakdown, and a potentially life-threatening condition known as Parkinsonism-Hyperpyrexia Syndrome.

Medication changes should always occur gradually under medical supervision.

Patients should also inform dentists, surgeons, anesthesiologists, and other healthcare providers about their Parkinson’s medications before any procedure because certain drugs interact with anesthetics or other treatments.

Future Medications

Scientists continue developing therapies that address the underlying disease process rather than simply replacing dopamine.

Current research includes:

• Alpha-synuclein antibodies
• Gene therapy
• Stem cell therapy
• Neuroprotective drugs
• Anti-inflammatory treatments
• Mitochondrial protective agents
• Growth factor therapy
• Precision medicine based on genetic profiles

The goal is to slow, halt, or eventually prevent the progression of Parkinson’s disease rather than only controlling symptoms.

Personalized Treatment

Perhaps the most important principle in Parkinson’s disease management is that treatment must be individualized.

A younger working professional, an active retiree, and an older patient with memory impairment each require different medication strategies. Neurologists continually adjust therapy according to changing symptoms, side effects, daily activities, occupational demands, and personal goals.

Successful treatment extends beyond medication alone. Regular exercise, healthy nutrition, adequate sleep, physical therapy, occupational therapy, speech therapy, emotional support, and strong family involvement all contribute to maintaining independence and quality of life.

Modern medications have transformed Parkinson’s disease from a rapidly disabling illness into a condition that many individuals successfully manage for decades. Although challenges remain, ongoing scientific advances continue to expand treatment options and offer hope for even more effective therapies in the future.

In the next chapter, we will explore advanced treatments for Parkinson’s disease, including Deep Brain Stimulation (DBS), continuous infusion therapies, focused ultrasound, emerging surgical techniques, and future innovations that provide additional options when medications alone are no longer sufficient.